Cardiovascular Outcomes in Patients on Hemodialysis following Drug-Eluting versus Bare-Metal Coronary Stents

Figure 1

Comparative outcomes at 30 days and 1 year in BMS versus DES propensity-matched ESRD patients undergoing PCI. No statistical difference between groups was noted. ^∗No stroke events were reported in either group. If there are fewer than 7 cases/events, the exact number is not disclosed per the Massachusetts Department of Public Health; hence, most individual 30-day events were suppressed; ^#composite endpoint of the occurrence of any of the events (death, MI, stroke, HF, and TVR); BMS, bare-metal stent; DES, drug-eluting stent; ESRD, end-stage renal disease; PCI, percutaneous intervention; MI, myocardial infarction; CHF, congestive heart failure; TVR, target vessel revascularization.